Form 4: BDX Executive Sells Shares Under 10b5-1 Plan

Becton Dickinson & Co. EVP Michael Feld sold 75 shares of common stock for $202.73 per share, as part of a pre-arranged 10b5-1 trading plan.

Summary

• Michael Feld, Executive Vice President, Chief Risk Officer, and President of Life Sciences at Becton Dickinson & Co. (BDX), reported a sale of common stock.
• The transaction involved the disposition of 75 shares of BDX common stock.
• The shares were sold at a price of $202.73 per share.
• Following this transaction, Michael Feld beneficially owns 16,431 shares of BDX common stock directly.
• This sale was executed on January 26, 2026, under a Rule 10b5-1 plan adopted on February 7, 2025.

Sentiment

Score: 5

Explanation: The sale of a small number of shares by an executive under a pre-arranged 10b5-1 plan is a routine event and does not significantly alter the company's outlook or the executive's overall stake.

Positives

• The transaction was executed under a pre-arranged Rule 10b5-1 plan, indicating a planned sale rather than a reaction to recent events.

Negatives

• An executive sold 75 shares of common stock, reducing their direct ownership in the company.

Stakeholder Impact

• Shareholders: Minimal impact as the sale of 75 shares by an executive is a very small transaction relative to the company's market capitalization and the executive's overall holdings.
• Employees, Customers, Suppliers, Creditors: No direct impact from this transaction.

Key Dates

Recommendation

The sale of 75 shares by an executive under a Rule 10b5-1 plan is a routine, pre-scheduled event and represents a negligible portion of the company's outstanding shares or the executive's total holdings. It does not provide new information that would alter the fundamental investment thesis for Becton Dickinson & Co.

Keywords

Becton Dickinson, BDX, Michael Feld, insider trading, Form 4, stock sale, 10b5-1 plan, executive compensation